Found 0 matching trials
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
PHASE3This study will evaluate the effectiveness and safety of denosumab in treat...
Location
Multiple Locations
TNFSF11 Inhibition and Fertility: a Prospective Study
PHASE2The receptor activator of NF-kB ligand (RANKL) system is considered importa...
Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
PHASE4Aim of this study is to evaluate in a population of old osteoporotic chroni...
Location
Clinique Médipole Cabestany
Effects of Denosumab Therapy for Japanese
N/AIn this study, the investigators would like to analyze the bone mineral den...
Location
Tomidahama Hospital
AVT03 With Xgeva in Healthy Male Subjects
PHASE1This study has been designed as a randomized, double-blind, parallel-group ...
Effect of RANKL Inhibition on UV-induced Immunosuppression
PHASE1Ultraviolet (UV) light is part of normal sunlight and has many effects on h...
Location
Innovaderm Research Inc.
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
PHASE4This study will compare the effectiveness of denosumab treatment every 6 mo...
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
PHASE3The purpose of this study is to describe the safety and tolerability of up ...
Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease
PHASE4Nonalcoholic fatty liver disease (NAFLD) is a chronic, metabolic liver dise...
Location
Department of Endocrinology, "Hippokration" General Hospital of Thessaloniki
Contribution of Bone to Urine Citrate
N/AIdentification of the mechanisms by which bone contributes to urine citrate...
Status
Enrolling By Invitation
Location
UT Southwestern Medical Center